Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy

SIMPLE SUMMARY: Adjuvant chemotherapy following radical cystectomy is a common therapy for muscle invasive bladder cancer (MIBC) patients. No applicable biomarkers exist to predict which patients will benefit from chemotherapy. Three immune cell markers, the chemokine CC motif ligand 2 (CCL2), the p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cells
Auteurs principaux: Taubert, Helge, Eckstein, Markus, Epple, Elena, Jung, Rudolf, Weigelt, Katrin, Lieb, Verena, Sikic, Danijel, Stöhr, Robert, Geppert, Carol, Weyerer, Veronika, Bertz, Simone, Kehlen, Astrid, Hartmann, Arndt, Wullich, Bernd, Wach, Sven
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7829767/
https://ncbi.nlm.nih.gov/pubmed/33467469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10010159
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires